Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is rated as an Elite provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

Dr. Spaide specializes in diseases of the retina and vitreous. His particular interests include retinal surgery, Macular Degeneration, Macular Holes, Macular Pucker, Diabetic Retinopathy, and intraocular inflammation. He has published more than 300 articles and 50 book chapters and 9 books about the diagnosis and treatment of Retinal Diseases. He has given lectures around the world.He has a remarkable number of “firsts” in retinal diseases including the development of autofluorescence imaging using a fundus camera and the first practical method to image deeper structures in the eye with optical coherence tomography. These imaging methods now are used around the world. He has described many new findings and diseases of the eye and helped develop many novel treatments. He has developed numerous surgical instruments that were named after him and holds patents for ophthalmic inventions.He is the recipient of the Richard and Hilda Rosenthal Foundation Award in the Visual Sciences, the Senior Honor Award from the American Society of Retinal Surgeons, and the Senior Achievement Award from the American Academy of Opthalmology and the Prix Soubrane de la Recherche en Ophthalmologie, Award of Merit from the Retina Society, the Henkind Award, Coscas Award, Nataraja Pillai Award, W. Richard Green MD Award, George Theodossiadis Award, Founders Award, American Society of Retinal Surgeons, Life Achievement Honor Award, and the American Academy of Ophthalmology. Dr. Spaide is rated as an Elite provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Central Serous Chorioretinopathy, and Vitrectomy.

Dr. Cooney is a practicing vitreoretinal surgeon who was previously an assistant professor of ophthalmology at Johns Hopkins University and later became the director of the Medical Retina Service, the Duke Center for Macular Degeneration, and the medical retina fellowship program from 2001 to 2005. He received a MBA degree from Kenan-Flagler Business School at the University of North Carolina, Chapel Hill.Dr. Cooney serves as a consultant and advisory board member for several pharmaceutical companies. In 1998, Dr. Cooney helped to establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics and served as a consultant from 2000 to 2002.Dr. Cooney’s clinical practice focuses on the medical and surgical treatment of vitreoretinal diseases, particularly age-related macular degeneration and diabetic retinopathy. He is actively involved in the clinical development of new diagnostic and therapeutic modalities for vitreoretinal disease and the training of residents and fellows.,Dr. Cooney helped establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics. Dr. Cooney is rated as an Experienced provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Stargardt Macular Degeneration, and Cone Rod Dystrophy Amelogenesis Imperfecta.

Dr. Fisher is a clinical ophthalmologist specializing in vitreoretinal diseases. Dr. Fisher’s career is noteworthy in the areas of patient care, teaching, and research. He is the author of several textbooks in the field of vitreoretinal diseases and ultrasonography.AuthorDr. Fisher has published more than 50 scientific articles and numerous scientific exhibits and posters. He was a course director for the American Academy of Ophthalmology for over 22 years and a review editor for many prestigious ophthalmic journals. He has received numerous awards for national and international professorships and lectureships. He has also been awarded the coveted Senior Award from the American Academy of Ophthalmology.LecturesDr. Fisher has lectured throughout the United States and abroad in the areas of ultrasonography and vitreoretinal surgery, developing new techniques and instruments in his field as well as pioneering developments in ocular endoscopy. He was selected by departmental chairmen and section chiefs at major ophthalmology centers nationwide as one of the 400 best retina doctors in America.Developed InstrumentsDr. Fisher has developed numerous intraocular surgical instruments which have advanced the field of vitreoretinal surgery. These instruments include electromagnets as well as endoscopic techniques for situations where microscopic visualization is limited or impossible. Dr. Fisher is rated as an Experienced provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), Retinal Detachment, and Vitrectomy.

Irene A. Barbazetto, M.D. is a vitreoretinal surgeon and macular disease specialist board certified in the United States and Europe. She is an internationally recognized expert in the treatment of macular degeneration, retinal vascular disease, retinal vein occlusion, hereditary retinal disease, and diabetes.The author of more than 40 peer-reviewed articles and book chapters, she serves on the Editorial Board of the prestigious journal Graefe’s Archive of Clinical and Experimental Ophthalmology. Dr. Barbazetto is the recipient of the 2009 Achievement Award from the American Academy of Ophthalmology. Her patients voted her as one of the best retina doctors, America’s “Most Compassionate Physicians,” and she received the “Patient’s Choice Award” in 2010. A graduate of Hamburg University, Germany, Dr. Barbazetto’s doctoral thesis investigated a newly developed vision-screening test (H-Test) for pre-school children and was awarded cum laude. She completed her ophthalmology residency in Lübeck, Germany, where she participated in the development of photodynamic therapy for the treatment of macular degeneration.In 2000, she came to New York for a research fellowship with Dr. Stanley Chang at Columbia University, focusing on the role of oxygen in the development of cataract after vitreoretinal surgery. She completed an internship in general surgery at the Lenox Hill Hospital in Manhattan and an ophthalmology residency at Columbia University. Dr. Barbazetto is rated as a Distinguished provider by MediFind in the treatment of Central Serous Chorioretinopathy. Her top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Adult-Onset Vitelliform Macular Dystrophy (AVMD).

Dr. Klancnik utilizes all forms of ophthalmic imaging including fluorescein angiography, indocyanine green angiography, as well as noninvasive forms of imaging such as spectral domain optical coherence tomography, autofluorescence photography, and ultrasonography.Dr. Klancnik is a magna cum laude graduate of Yale University. He earned his medical degree from Jefferson Medical College of Thomas Jefferson University and was elected to the Alpha Omega Alpha and Hobart Amory Hare honor medical societies. He completed his internship at the Lankenau Hospital and his ophthalmology residency at Wills Eye Hospital. He completed his medical and surgical vitreoretinal fellowship at Manhattan Eye, Ear & Throat Hospital and Columbia University. He is an Assistant Professor of Clinical Ophthalmology at New York University School of Medicine.Dr. Klancnik is a member of numerous medical organizations including the American Academy of Ophthalmology, American Society of Retinal Specialists, and Association for Research in Vision and Ophthalmology. He is an author of numerous peer-reviewed journal articles and book chapters and has presented at scientific meetings nationally and internationally. He is active in numerous clinical trials as principle or sub-investigator and serves as a reviewer for several ophthalmology journals. Dr. Klancnik is rated as a Distinguished provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Vein Occlusion.

"William M. Schiff, MD is a board certified Ophthalmologist, specializing in the medical and surgical management of vitreous and retinal diseases. He is the Director of Ophthalmic Surgery at Manhattan Eye Ear and Throat Hospital (MEETH) and serves an educational role as the Co-Director of the Vitreoretinal Fellowship Program. Dr. Schiff's practice encompasses the management of medical and surgical diseases of the vitreous, retina, and macula including macular degeneration, macular hole, epiretinal membrane, diabetic retinopathy and retinal detachment. Dr. Schiff was previously Professor of Clinical Ophthalmology at Columbia University, College of Physicians and Surgeons. He has lectured widely, has authored or coauthored more than 50 publications, and is an active member of numerous professional societies and organizations including The American Academy of Ophthalmology, The Retina Society, The American Society of Retinal Specialists and the New York Ophthalmologic Society. Dr. Schiff has earned the Achievement Award from the American Academy of Ophthalmology and the Honor's Award from the American Society of Retina Specialists. He has been named in ""New York Magazine's Best Doctors. Dr. Schiff is rated as an Experienced provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Retinal Detachment, Vitrectomy, and Cataract Removal.

John Khadem is an Ophthalmologist in New York, New York. Dr. Khadem is rated as a Distinguished provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Retinal Detachment, Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, and Age-Related Macular Degeneration (ARMD).

K. Bailey Freund, MD specializes in diagnosis, treatment and care of patients with all retinal disorders including macular degeneration, diabetic retinopathy, and retinal vascular and inflammatory diseases and is an expert in difficult-to-diagnose and rare conditions. He has been at the forefront of pivotal national clinical trials as a principal investigator for treatments for retinal diseases, providing his patients access to the latest solutions and remedies utilizing the most state of the art diagnostic equipment.Dr. Freund is internationally recognized in his field and is a member of the Retina Society, Macula Society, and the American Society of Retina Specialists. He is on the Editorial Board of the journal Retina and is an Associate Editor for Retinal Cases & Brief Reports. He has authored over 250 peer-reviewed scientific manuscripts and has written numerous book chapters. He has received numerous awards including the prestigious Young Investigator Award from the Macula Society.He is a graduate of Williams College and the New York University School of Medicine and completed his residency training in general ophthalmology and fellowship in medical and surgical retina at the Manhattan Eye, Ear, and Throat Hospital. Dr. Freund was born and raised in Manhattan and continues to reside here with his wife and his two children. Dr. Freund enjoys playing the guitar and is a prominent collector of vintage magic apparatus. Dr. Freund is rated as a Distinguished provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Choroid Plexus Carcinoma.

Michael Engelbert, MD, PhD, a vitreoretinal surgeon and macular disease specialist, provides both medical care for age-related macular degeneration and diabetic eye disease as well as surgical management of macular disease and retinal detachment repair, including complex detachments from diabetes and after trauma or failed primary repair. He also specializes in secondary intraocular lens implantation after complicated cataract surgery. He is an internationally renowned expert on vitreous anatomy and vitreoretinal interface disorders, topics on which he lectures at home and abroad.Dr. Engelbert received his medical degree Magna Cum Laude from Ludwig-Maximilians-University in Munich, Germany, after which he dedicated himself several years to basic research in the study of endophthalmitis, a vision-threatening infection, that can occur after eye surgery. He earned a Ph.D. for this work and is considered a leader in this field.Before joining the residency program at Columbia University, Dr. Engelbert served his internship at Griffin Hospital, a Yale-affiliated center in Connecticut, where he was granted the Vincent D. DeLuca award for the best medical intern.Afterward, he was resident and chief resident in the Department of Ophthalmology of Columbia University’s College of Physicians and Surgeons at the Edward S. Harkness Eye Institute on the Columbia Presbyterian Medical Center Campus. Following his residency training, Dr. Engelbert was awarded a medical and surgical vitreoretinal fellowship at Manhattan Eye, Ear & Throat Hospital and Columbia University.Dr. Engelbert is a member of The American Society of Retina Specialists (ASRS), The European Society of Vitreoretinal Specialists (EVRS), the Association for Research in Vision and Ophthalmology (ARVO), and The American Academy of Ophthalmology (AAO) and the prestigious Club Jules Gonin. He has published numerous papers on retinal disease, received several awards and has been granted permanent resident status in the United States in the category “outstanding scientist”. He serves as a reviewer for the premier journals in the field, including the Archives of Ophthalmology, Ophthalmology, Investigative Ophthalmology and Visual Sciences, Retina, Eye, and Graefe’s Archives of Clinical and Experimental Ophthalmology.He is a Research Assistant Professor at New York University and Clinical Instructor at NYU , where he is actively involved in instructing residents and fellows in the art of medical retina and retinal surgery, and provides care for an underserved population with often advanced disease requiring complex surgical intervention. Dr. Engelbert is rated as an Advanced provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Iridectomy.

Naomi Goldberg is an Ophthalmologist in New York, New York. Dr. Goldberg is rated as an Advanced provider by MediFind in the treatment of Central Serous Chorioretinopathy. Her top areas of expertise are Uveitis, Birdshot Chorioretinopathy, Scleritis, and Neuroretinitis.

Talia Kaden is a General Surgeon and an Ophthalmologist in New York, New York. Dr. Kaden is rated as an Advanced provider by MediFind in the treatment of Central Serous Chorioretinopathy. Her top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Iridectomy.

Ian Chan is an Ophthalmologist in New York, New York. Dr. Chan is rated as an Advanced provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Retinal Vein Occlusion, Retinal Artery Occlusion, Neuroretinitis, and Late-Onset Retinal Degeneration.

Joseph Tseng is an Ophthalmologist in New York, New York. Dr. Tseng is rated as an Advanced provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Diabetic Retinopathy, Retinal Detachment, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Vitrectomy.

Jonathan Feistmann is an Ophthalmologist in New York, New York. Dr. Feistmann is rated as an Advanced provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Retinal Detachment, Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), and Late-Onset Retinal Degeneration. Dr. Feistmann is currently accepting new patients.

Meenakashi Gupta is an Ophthalmologist in New York, New York. Dr. Gupta is rated as an Advanced provider by MediFind in the treatment of Central Serous Chorioretinopathy. Her top areas of expertise are Diabetic Retinopathy, Endophthalmitis, Late-Onset Retinal Degeneration, Trabeculectomy, and Vitrectomy. Dr. Gupta is currently accepting new patients.

Cristiana Pieroni is an Ophthalmologist in New York, New York. Dr. Pieroni is rated as an Advanced provider by MediFind in the treatment of Central Serous Chorioretinopathy. Her top areas of expertise are Retinal Detachment, Diabetic Retinopathy, Late-Onset Retinal Degeneration, and Central Serous Chorioretinopathy.

Gennady Landa is an Ophthalmologist in New York, New York. Dr. Landa is rated as an Advanced provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Retinal Detachment, Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Cataract Removal. Dr. Landa is currently accepting new patients.

Richard Rosen is an Ophthalmologist in New York, New York. Dr. Rosen is rated as an Advanced provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Retinitis Pigmentosa, X-Linked Retinitis Pigmentosa (XLRP), Endophthalmitis, and Doyne Honeycomb Retinal Dystrophy.

Gaurav Chandra is an Ophthalmologist in New York, New York. Dr. Chandra is rated as an Advanced provider by MediFind in the treatment of Central Serous Chorioretinopathy. His top areas of expertise are Endophthalmitis, Neuroretinitis, Uveitis, Late-Onset Retinal Degeneration, and Vitrectomy. Dr. Chandra is currently accepting new patients.